News cyclin.

More is being learned about CDK12 and its role across a host of cancers. This retrospective look at over 25K patients undergoing tumor sequencing at MSKCC reports over 5% of prostate cancers harbor a CDK12 alteration portending more aggressive cancers and worse survival. | Nguyen, Eur Urol 2020


Popular Posts